thiocyanate has been researched along with Coronary Disease in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (30.00) | 18.7374 |
1990's | 7 (70.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rabkin, SW | 1 |
Archbold, GP; Cupples, ME; Linton, T; McKnight, A | 1 |
Moohan, M; Tunstall-Pedoe, H; Woodward, M | 1 |
Ockene, JK; Shaten, BJ | 1 |
Hymowitz, N; Lagus, J; Ockene, JK; Shaten, BJ | 1 |
Bodurtha, JN; Bossano, R; Hewitt, JK; Moskowitz, WB; Mosteller, M; Schieken, RM; Segrest, JP | 1 |
Kuller, LH; Meilahn, E; Ockene, JK; Svendsen, KH | 1 |
Cutter, GR; Haley, NJ; Hughes, GH; Jacobs, DR; Manolio, TA; Sidney, S; Wagenknecht, LE | 1 |
Curran, JP; Habif, V; Sirota, AD | 1 |
Grimm, RH; Ludwig, W; Neaton, JD | 1 |
3 trial(s) available for thiocyanate and Coronary Disease
Article | Year |
---|---|
Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. A control clinical trial.
Topics: Adult; Blood Glucose; Blood Pressure; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Humans; Male; Risk; Smoking; Thiocyanates; Triglycerides | 1984 |
The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT).
Topics: Adult; Confidence Intervals; Coronary Disease; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Random Allocation; Recurrence; Risk; Risk Factors; Smoking; Smoking Prevention; Thiocyanates | 1990 |
Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality.
Topics: Adult; Cholesterol; Coronary Disease; Humans; Leukocyte Count; Male; Middle Aged; Mortality; Neoplasms; Prognosis; Smoking; Thiocyanates | 1985 |
7 other study(ies) available for thiocyanate and Coronary Disease
Article | Year |
---|---|
Measurement of markers of tobacco smoking in patients with coronary heart disease.
Topics: Adult; Aged; Biomarkers; Breath Tests; Carbon Monoxide; Coronary Disease; False Positive Reactions; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; ROC Curve; Smoking; Thiocyanates | 1995 |
Self-reported smoking, cigarette yields and inhalation biochemistry related to the incidence of coronary heart disease: results from the Scottish Heart Health Study.
Topics: Adult; Biomarkers; Carbon Monoxide; Cohort Studies; Coronary Disease; Cotinine; Female; Humans; Incidence; Male; Middle Aged; Risk Factors; Scotland; Smoking; Surveys and Questionnaires; Thiocyanates | 1999 |
Cigarette smoking in the Multiple Risk Factor Intervention Trial (MRFIT). Introduction, overview, method, and conclusions.
Topics: Adult; Blood Pressure; Body Weight; Carbon Monoxide; Cholesterol; Clinical Trials as Topic; Cohort Studies; Coronary Disease; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Smoking; Smoking Prevention; Thiocyanates | 1991 |
Comparison of smoking behavior change for SI and UC study groups. MRFIT Research Group.
Topics: Adult; Carbon Monoxide; Clinical Trials as Topic; Cohort Studies; Coronary Disease; Follow-Up Studies; Health Promotion; Humans; Male; Middle Aged; Program Evaluation; Risk Factors; Smoking Cessation; Smoking Prevention; Thiocyanates | 1991 |
Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study.
Topics: 2,3-Diphosphoglycerate; Child; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diphosphoglyceric Acids; Diseases in Twins; Echocardiography; Female; Humans; Lipoproteins; Male; Oxygen; Risk Factors; Thiocyanates; Tobacco Smoke Pollution; Twins | 1990 |
Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study.
Topics: Adolescent; Adult; Black People; Confidence Intervals; Coronary Disease; Cotinine; Female; Humans; Linear Models; Longitudinal Studies; Male; Pyrrolidinones; Racial Groups; Risk Factors; Smoking; Thiocyanates; White People | 1990 |
Smoking cessation in chronically ill medical patients.
Topics: Behavior Therapy; Carbon Monoxide; Chronic Disease; Coronary Disease; Feedback; Follow-Up Studies; Humans; Lung Diseases; Male; Middle Aged; Smoking; Thiocyanates; Tobacco Use Disorder | 1985 |